Last updated: March 22, 2024
Sponsor: Ardahan University
Overall Status: Completed
Phase
N/A
Condition
Ulcers
Ulcerative Colitis
Inflammatory Bowel Disease
Treatment
Curcumin Supplementation
Mediterranean Diet
Resveratrol Supplementation
Clinical Study ID
NCT05761327
2021/24
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male and female patients aged >18 years,
- Those previously diagnosed with ulcerative colitis and/or newly diagnosed withclinical course, consistent histology and endoscopy by a gastroenterologist,
- Mild and Moderate activity disease was confirmed by the Truelove-Witts Severity Index,
- Using a fixed dose of 5 - aminosalicylic acid (mesalazine) and/or azathioprine,
- Who did not receive nutrition therapy in the last 3 months,
- Not using anti-inflammatory drugs and antibiotic drugs in the last 4 weeks,
- Not using curcumin and resveratrol supplements before participating in the study,
- Agreeing to participate in the study voluntarily,
Exclusion
Exclusion Criteria:
- Women during pregnancy or lactation
- Not meeting the inclusion criteria,
- History of chronic disease (such as diabetes), hypothyroidism and hyperthyroidism,liver, kidney and cardiovascular diseases, polycystic ovary syndrome and Cushing'ssyndrome,
- Taking one of the anti-inflammatory and antibiotic drugs,
Study Design
Total Participants: 48
Treatment Group(s): 3
Primary Treatment: Curcumin Supplementation
Phase:
Study Start date:
June 03, 2022
Estimated Completion Date:
March 22, 2024
Study Description
Connect with a study center
Inonu University Turgut Ozal Medical Center
Malatya, 44200
TurkeySite Not Available
Malatya Training and Research Hospital
Malatya, 44200
TurkeySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.